Investor Calendar

Investor Calendar

  • Annual general meeting
  • Q2 report, 2018/19

Upcoming events

  • Meet us at a conference devoted to the problem of primary and acquired therapy resistance associated with disease progression and poor clinical outcome in cancer patients.